Nicholas Ramey, MD
Ophthalmic Plastic and Reconstructive Surgery · Roanoke, VANPI 1104008226
Payments from drug & device makers
Across 116 payments — averaging $134.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$12K
- Glaukos Corporation$3K
- AbbVie$293
- Merz Pharmaceuticals, LLC$282
- Regeneron$210
- Alcon$145
- plus $346 from 9 others
What the payments were for
- Speaking & faculty fees$13,43486%
- Food & beverage$2,12414%
- Education$660%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 72 | $11,688 |
| Glaukos Corporation | 2 | $2,679 |
| AbbVie(2 entities) | 11 | $293 |
| Merz Pharmaceuticals, LLC | 12 | $282 |
| Regeneron | 4 | $210 |
| Alcon | 2 | $145 |
| Bausch & Lomb Americas Inc. | 1 | $116 |
| Biotissue Holdings Inc. | 2 | $58 |
| Tarsus Pharmaceuticals, Inc. | 2 | $42 |
| Argenx US, Inc. | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $21 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Organogenesis Inc. | 1 | $17 |
| Rayner Intraocular Lenses Limited | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$10,879
- iStent Trabecular Micro-Bypass System Model iS3$2,500
- KXL System$179
- iStent infinite Trabecular Micro-Bypass System Model iS3$179
- LenSx$132
- BTOD$116
- INFUSE$116
- OZURDEX$115
How this compares
Too few ophthalmic plastic and reconstructive surgery providers in Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TepezzaTeprotumumab-Trbw | 32 | $1,666,947 |
| ErythromycinErythromycin Base | 725 | $6,678 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 144 | $1,331 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 239 | $1,195 |
| Bacitracin-PolymyxinBacitracin/Polymyxin B Sulfate | 97 | $1,167 |
| Doxycycline Hyclate | 47 | $749 |
| Cephalexin | 136 | $524 |
| Atropine Sulfate | 14 | $469 |
| MoxifloxacinMoxifloxacin Hcl | 22 | $420 |
| Ciprofloxacin Hcl | 16 | $201 |
| Ondansetron OdtOndansetron | 11 | $159 |
| Clindamycin Hcl | 36 | $133 |
| Doxycycline Monohydrate | 12 | $93 |
| Sodium Chloride0.9 % Sodium Chloride | 11 | $29 |
| Tramadol Hcl | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenTepezza | $11,688 | $1,666,94732 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few ophthalmic plastic and reconstructive surgery providers in Virginiaon file to place this against a meaningful peer group, so we don't.
Other ophthalmic plastic and reconstructive surgery in Roanoke
- Maria KirzhnerCharlottesville$68K
- Roger NewsomPortsmouth$5K
- Viraj MehtaMc Lean$2K
- Maryam NazemzadehAshburn$2K
- William BeardenRichmond$284
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.